For the Inventor, By the Inventor

Enter assignee name

Branford, CT, United States of America

Cgi Pharmaceuticals, Inc.

USPTO Granted Patents = 13

EPO Patents = 1

Forward Citations = 346

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Scott A Mitchell (13 out of 67 patents)

Kevin S Currie (9 out of 72 patents)

Robert W DeSimone (8 out of 34 patents)

4. Douglas A Pippin (7 out of 8 patents)

5. Peter A Blomgren (6 out of 53 patents)

6. James William Darrow (6 out of 16 patents)

7. Jeffrey E Kropf (4 out of 45 patents)

8. Seung H Lee (4 out of 37 patents)

9. Aaron C Schmitt (3 out of 25 patents)

10. Jianjun Xu (3 out of 40 patents)

11. Pavel E Zhichkin (3 out of 14 patents)

12. David R Brittelli (3 out of 20 patents)

13. Zhongdong Zhao (2 out of 32 patents)

14. Mihaela Diana Danca (2 out of 13 patents)

15. Douglas A I Pippin (2 out of 2 patents)

13 patents: Sort by Forward Citations

1. 8426424 - Certain substituted amides, method of making, and method of use thereof (2013-04-23),

2. 7947835 - Certain substituted amides, method of making, and method of use thereof (2011-05-24),

3. 7884108 - Certain substituted pyrazinones (2011-02-08),

4. 7838523 - Certain substituted amides, method of making, and method of use thereof (2010-11-23),

5. 7777040 - Certain substituted ureas, as modulators of kinase activity (2010-08-17),

6. 7625931 - Certain substituted diphenyl ureas, as modulators of kinase activity (2009-12-01),

7. 7405295 - Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds (2008-07-29),

8. 7393848 - Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds (2008-07-01),

9. 7312341 - 6-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making, and method of use thereof (2007-12-25),

10. 7259164 - Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity (2007-08-21),

11. 7189723 - Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity (2007-03-13),

12. 7160885 - Certain 6, 8-(heteroaryl or aryl) disubstituted imidazo[1,2-a]pyrazines as modulators of Hsp90 complex activity (2007-01-09),

13. 7015227 - Certain amino-substituted monocycles as kinase modulators (2006-03-21),

Company Overview

Cgi Pharmaceuticals, Inc. is a biopharmaceutical company based in Branford, Connecticut, specializing in the development of innovative therapies for various medical conditions. The organization focuses on advancing drug candidates through rigorous research and clinical trials, particularly in the fields of neurology and psychiatry. Cgi Pharmaceuticals is dedicated to addressing unmet medical needs and improving patient outcomes by leveraging cutting-edge scientific knowledge and technology in its drug development processes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

13 Patents

#14 in Branford, CT

#523 in Connecticut

#23,854 in US

#45,081 in the World

Branford, CT, United States of America

Cgi Pharmaceuticals, Inc.

Forward Citations = 346

23 inventors:

Scott A Mitchell (13 out of 67 patents)

Kevin S Currie (9 out of 72 patents)

Robert W DeSimone (8 out of 34 patents)

4. Douglas A Pippin (7 out of 8 patents)

5. Peter A Blomgren (6 out of 53 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cgi Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/cgi-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…